Explore more about: Magnetic Resonance Imaging (MRI)

A new MRI technology creates images resolved enough to enable consistent diagnoses across populations for the first time.

A new phase 1 clinical trial evaluated the differences between pre-operative prone and supine MRI exams in 12 women undergoing lumpectomy for breast cancer.

Study describes the use of restriction spectrum imaging as a biomarker that enhances the ability of MRI to differentiate aggressive cancer from benign tumors.

Researchers develop a way to prepare mesenchymal stem cells leading to the production of more native stem cells, and label them with an iron-oxide nanoparticle.

Scientists have discovered a new class of molecular tags that enhance MRI signals by 10,000-fold and generate detectable signals that last over an hour.

A new way to analyze breast cancer MRI data appears to reliably distinguish between patients who would need hormonal treatment versus needing chemotherapy.